Abstract
Understanding the adaptive immune response is an area of research critically important in medicine. Several positive regulators of B- and T-cell activation exist to eliminate pathogens, in which CD40 ligand (CD154) plays a fundamental role. It is well documented that CD154 expressed by CD4 T helper cells can be critical in the proper activation of dendritic cells for the productive stimulation of CD8 T cells and is required for proper T-dependent B-cell immunity. However, platelets are an abundant and systemic source of CD154. While classically known to be important for hemostasis and inflammation, several lines of evidence suggest that platelet-derived ligands can modulate the adaptive immune compartment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ahmad R, Menezes J, Knafo L et al (2001) Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells. J Leukoc Biol 69: 123–128
Aslam R, Speck ER, Kim M et al (2006) Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107: 637–641
Aslam R, Speck ER, Kim M et al (2008) Transfusion-related immunomodulation by platelets is dependent on their expression of MHC class I molecules and is independent of white cells. Transfusion 48: 1778–1786
Baj-Krzyworzeka M, Majka M, Pratico D et al (2002) Platelet–derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30: 450–459
Banchereau J, Briere F, Caux C et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767–811
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252
Bennett SR, Carbone FR, Karamalis F et al (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478–480
Bigalke B, Lindemann S, Ehlers R et al (2006) Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J 27: 2165–2169
Borrow P, Tishon A, Lee S et al (1996) CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 183: 2129–2142
Boukour S, Cramer EM (2005) Platelet interaction with bacteria. Platelets 16: 215–217
Brincks EL, Katewa A, Kucaba TA et al (2008) CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol 181: 4918–4925
Bucki R, Pastore J (2006) Bacterial endotoxin as inhibitor of the enzymatic activity of human thrombin. Eur J Haematol 76: 510–515
Byrne MF, Kerrigan SW, Corcoran PA et al (2003) Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 124: 1846–1854
Cabeza N, Li Z, Schulz C (2004) Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53: 2117–2121
Caux C, Massacrier C, Vanbervliet B et al (1994a) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180: 1263–1272
Clark SR, Ma AC, Tavener SA et al (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13: 463–469
Clarkson MR, Sayegh MH (2005) T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 80: 555–563
Cognasse F, Payrat JM, Corash L et al (2008) Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand. Blood 112: 4779–4780
Crist SA, Elzey BD, Ludwig AT et al (2004) Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets. Exp Hematol 32: 1073–1081
Crist SA, Sprague DL, Ratliff TL (2008) Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes. Blood 111: 3553–3561
Czapiga M, Kirk AD, Lekstrom-Himes J (2004) Platelets deliver costimulatory signals to antigen-presenting cells: A potential bridge between injury and immune activation. Exp Hematol 32: 135–139
Damas JK, Waehre T, Yndestad A et al (2003) Interleukin-7–mediated inflammation in unstable angina: possible role of chemokines and platelets. Circulation 107: 2670–2676
Danese S, de la Motte C, Reyes BM et al (2004) Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 172: 2011–2015
Danese S, Fiocchi C (2005) Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol 25: 103–121
Danese S, Sans M, Scaldaferri F et al (2006) TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in crohn’s disease. J Immunol 176: 2617–2624
Danese S, Scaldaferri F, Vetrano S et al (2007) Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut 56: 1248–1256
Delmas Y, Viallard JF, Solanilla A et al (2005) Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. Kidney Int 68: 2068–2078
Elzey BD, Grant JF, Sinn HW et al (2005a) Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol 78: 80–84
Elzey BD, Schmidt NW, Crist S.A. et al (2008) Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood 111: 3684–3691
Elzey BD, Sprague DL, Ratliff TL (2005b) The emerging role of platelets in adaptive immunity. Cell Immunol 238: 1–9
Elzey BD, Tian J, Jensen RJ et al (2003) Platelet-mediated modulation of adaptive immunity: a communication link between innate and adaptive immune compartments. Immunity 19: 9–19
Fleischer J, Grage-Griebenow E, Kasper B et al (2002) Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells. J Immunol 169: 770–777
George JN (2000) Platelets. Lancet 355: 1531–1539
Gouttefangeas C, Diehl M, Keilholz W et al (2000) Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro. Blood 95: 3168–3175
Gresele P, Falcinelli E, Momi S (2008) Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. Trends Pharmacol Sci 29: 352–360
Hamzeh-Cognasse H, Cognasse F, Palle S et al (2008) Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol 9: 54
Han S, Hathcock K, Zheng B et al (1995) Cellular interaction in germinal centers. Roles of CD 40 ligand and B7-2 in established germinal centers. J Immunol 155: 556–567
Heijnen HF, Schiel AE, Fijnheer R et al (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha -granules. Blood 94: 3791–3799
Held W, Shakhov AN, Izui S et al (1993) Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med 177: 359–366
Henn V, Slupsky JR, Grafe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391: 591–594
Hilf N, Singh-Jasuja H, Schwarzmaier P et al (2002) Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood 99: 3676–3682
Iannacone M, Sitia G, Isogawa M et al (2005) Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 11: 1167–1169
Iannacone M, Sitia G, Isogawa M et al (2008) Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL–dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci USA 105: 629–634
Iannacone M, Sitia G, Narvaiza I et al (2007) Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin VaccineImmunol 14: 1532–1535
Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987–995
Kalvegren H, Majeed M, Bengtsson T (2003) Chlamydia pneumoniae binds to platelets and triggers p-selectin expression and aggregation: a causal role in cardiovascular disease?. Arterioscler Thromb Vasc Biol 23: 1677–1683
Kaneider NC (2003) CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int J Immunopathol Pharmacol 16: 225–231
Khandoga A, Hanschen M, Kessler JS et al (2006) CD4 T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 43: 306–315
Kissel K, Berber S, Nockher A et al (2006) Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion 46: 818–827
Klinger MH (1997) Platelets and inflammation. Anat Embryol 196: 1–11
Lang PA, Contaldo C, Georgiev P et al (2008) Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 14: 756–761
Liu CY, Battaglia M, Lee SH et al (2005) Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25– (nonregulatory) T cells. J Immunol 174: 2680–2686
Lougaris V, Badolato R, Ferrari S et al (2005) Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 203: 48–66
Mach F, Schonbeck U, Libby P (1998) CD40 signaling in vascular cells: a key role in atherosclerosis. Atherosclerosis 137(suppl): S89–95
Martinson JA, Bae J, Klingemann HG et al (2004) Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. Cytotherapy 6: 487–497
Miller C, Stedra J, Kelsoe G et al (1995) Facultative role of germinal centers and T cells in the somatic diversification of IgVH genes. J Exp Med 181: 1319–1331
Mirlashari MR, Hagberg IA, Lyberg T (2002) Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis. Platelets 13: 91–99
Nagaraj S, Gabrilovich DI (2007) Myeloid-derived suppressor cells. Adv Exp Med Biol 601: 213–223
Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor?. Blood 102: 449–461
Otterdal K, Pedersen TM, Solum NO (2004) Release of soluble CD40 ligand after platelet activation: Studies on the solubilization phase. Thromb Res 114: 167–177
Pitti RM, Marsters SA, et al (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687–12690
Redmond WL, Sherman LA (2005) Peripheral tolerance of CD8 T lymphocytes. Immunity 22: 275–284
Renshaw BR, Fanslow WC 3rd, Armitage RJ et al (1994a) Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 180: 1889–1900
Schoenberger SP, Toes RE, van der Voort EI et al (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions. Nature 393: 480–483
Schonbeck U, Libby P (2001) The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58: 4–43
Sidiropoulos PI, Boumpas DT (2004) Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients. Lupus 13: 391–397
Solanilla A, Pasquet J-M, Viallard J-F et al (2005) Platelet–associated CD154 in immune thrombocytopenic purpura. Blood 105: 215–218
Soslau G, Morgan DA, Jaffe JS et al (1997) Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. Cytokine 9: 405–411
Sprague DL, Elzey BD, Crist SA et al (2008) Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 111: 5028–5036
van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67: 2–17
Varo N, Libby P, Nuzzo R et al (2005) Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products. Diab Vasc Dis Res 2: 81–87
Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8: 523–532
Wang CL, Wu YT, Liu CA et al (2003) Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 111: E140–147
Weissmüller T, Campbell EL, Rosenberger P et al (2008) PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell–expressed ecto-NTPDases. J Clin Invest 118: 3682–3692
Xu H, Zhang X, Mannon RB et al (2006) Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest 116: 769–774
Yang Y, Su Q, Grewal IS et al (1996) Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol 70: 6370–6377
Youssefian T, Drouin A, Masse J-M et al (2002) Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 99: 4021–4029
Zietkowski Z, Skiepko R., Tomasiak MM et al (2008) Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction. J Investig Allergol Clin Immunol 18: 272–278
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sowa, J.M., Crist, S.A., Ratliff, T.L. et al. Platelet influence on T- and B-cell responses. Arch. Immunol. Ther. Exp. 57, 235–241 (2009). https://doi.org/10.1007/s00005-009-0032-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-009-0032-y